Cargando…
Modulation of pro-inflammatory activation of monocytes and dendritic cells by aza-bis-phosphonate dendrimer as an experimental therapeutic agent
INTRODUCTION: Our objective was to assess the capacity of dendrimer aza-bis-phosphonate (ABP) to modulate phenotype of monocytes (Mo) and monocytes derived dendritic cells (MoDC) activated in response to toll-like receptor 4 (TLR4) and interferon γ (IFN- γ) stimulation. METHODS: Mo (n = 12) and MoDC...
Autores principales: | Degboé, Yannick, Fruchon, Séverine, Baron, Michel, Nigon, Delphine, Turrin, Cédric Olivier, Caminade, Anne-Marie, Poupot, Rémy, Cantagrel, Alain, Davignon, Jean-Luc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060464/ https://www.ncbi.nlm.nih.gov/pubmed/24745366 http://dx.doi.org/10.1186/ar4546 |
Ejemplares similares
-
An Anti-Inflammatory Poly(PhosphorHydrazone) Dendrimer Capped with AzaBisPhosphonate Groups to Treat Psoriasis
por: Jebbawi, Ranime, et al.
Publicado: (2020) -
An Azabisphosphonate-Capped Poly(phosphorhydrazone) Dendrimer for the Treatment of Endotoxin-Induced Uveitis
por: Fruchon, Séverine, et al.
Publicado: (2013) -
Biodistribution and Biosafety of a Poly(Phosphorhydrazone) Dendrimer, an Anti-Inflammatory Drug-Candidate
por: Fruchon, Séverine, et al.
Publicado: (2019) -
The key role of the scaffold on the efficiency of dendrimer nanodrugs
por: Caminade, Anne-Marie, et al.
Publicado: (2015) -
Pro-Inflammatory Versus Anti-Inflammatory Effects of Dendrimers: The Two Faces of Immuno-Modulatory Nanoparticles
por: Fruchon, Séverine, et al.
Publicado: (2017)